Nevertheless, some limitations of the present study remain to be addressed: first, this study was not aimed at elucidating pathophysiological pathways of Gas6 in SS, but was rather designed to evaluate its possible clinical significance. The gene discussed is GAS6; the disease is synovial sarcoma.